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Objective. To compare the safety, efficacy, and direct cost during the introduction of laparoscopic radical hysterectomy within
an enhanced recovery pathway. Methods. A 1 : 1 single centre retrospective case control study of 36 propensity matched pairs
of patients receiving open or laparoscopic surgery for early cervical cancer. Results. There were no significant differences in the
baseline characteristics of the two cohorts. Open surgery cohort had significantly higher intraoperative blood loss (189 versus
934mL) and longer postoperative hospital stay (2.3 versus 4.1 days). Although no significant difference in the intraoperative or
postoperative complications was found more urinary tract injuries were recorded in the laparoscopic cohort. Laparoscopic surgery
had significantly longer duration (206 versus 159minutes), lower lymph node harvest (12.6 versus 16.9), and slower bladder function
recovery.Themedian direct hospital cost was m4850 for laparoscopic radical hysterectomy and m4400 for open surgery.Conclusions.
Laparoscopic radical hysterectomy can be safely introduced in an enhanced recovery environment without significant increase in
perioperative morbidity.The 10% higher direct hospital cost is not statistically significant and is expected to even out when indirect
costs are included.
1. Introduction
Radical hysterectomy with pelvic lymphadenectomy is the
suggested treatment for cervical cancer FIGO stages 1A2 to
1B1 [1]. In 2010 theNational Institute forClinical Excellence in
England (NICE) supported the introduction of laparoscopic
radical hysterectomy (LRH) [2]. Since then the laparoscopic
approach is being adopted by gynaecological oncology units.
High quality evidence for the comparison of open versus
the laparoscopic route of radical hysterectomy is lacking
[3]. The only reported randomised controlled trial (RCT)
included 30women and revealed superior early postoperative
pain outcomes in the laparoscopic arm at the expense of
higher major complication rate [4]. An adequately powered
RCT would require a sample size up to 1400 patients to
detect differences in the safety outcomes between the two
techniques [5]. Available evidence is therefore derived from
large retrospective case series.The value of such studies in the
assessment of implementation of novel surgical techniques
has been criticised to obscure results during the learning
curve of the technique [6]. The already low incidence of
cervical cancer in the developed countries where advanced
laparoscopic surgery is commonly available is expected to
decrease further following the implementation of HPV vac-
cination programs.This along with the expanding availability
of radiotherapywill eventually decrease the number of radical
hysterectomies performed. Furthermore early diagnosis and
surgery for small volume disease allow modified radical
hysterectomies (type B) for which available comparison data
are even less. In the modern practice of higher turnover of
surgeons, evidence derived from studies assessing the learn-
ing curve of less commonly performed surgical techniques
may be of higher clinical relevance.
The implications of enhanced recovery perioperative
pathways (ERP) in the clinical outcomes and cost of laparo-
scopic radical hysterectomy have not been assessed in any
reported studies. This study is assessing safety outcomes
during the implementation phase of LRH in a tertiary
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institution. An effort was made to include all short and
long-term postoperative complications. Patients presenting
with complications to different hospitals were sought and
their outcomes were also included. The transparent and
honest report of surgical outcomes is essential for clinical
governance. Finally the estimation of direct hospital cost
during the introduction of the laparoscopic technique and
its comparison with this of open surgery is important for the
allocation of resources.
2. Materials and Methods
Institutional board approval was granted for the study. This
single centre study was performed at Liverpool Women’s
Hospital, a tertiary gynaecological cancer referral centre for
Merseyside and Cheshire cancer network which serves a
population of 2.3million. ERPwas introduced in January 2011
and LRH in June 2012. Between January 2011 and December
2013 a total of 102 radical hysterectomies were performed
for the treatment of cervical cancer and 36 of them were
laparoscopic. There were no cases treated with neoadju-
vant chemotherapy. After propensity score matching the 36
laparoscopic cases of RHwerematchedwith 36 cases of ARH.
The confounders selected for propensity scorematching were
age, BMI, ASA grade, FIGO stage, and previous abdominal
surgery (yes or no).These variables are considered significant
for patient selection for surgery and are also associated with
outcomes.
In accordance with NICE recommendations LRH was
offered to patients selected by the multidisciplinary gynae-
cological oncology team [2]. The radical hysterectomies
performed in both cohorts were mainly B1/2 type and the
lymphadenectomies level 1, according to the 2008 Querleu
and Morrow classification [7]. Laparoscopic surgery was
performed via a 10mmumbilical optical port and three 5mm
lateral ancillary operative ports. Nerve sparing techniques
were not actively pursued.
The direct hospital cost for each procedure was calculated
as the sum of three main categories; the cost of surgical time
and standard surgical equipment; the length of hospital stay
(including the cost of high dependency unit when used); the
procedure related perioperative expenses. In this last category
we included the cost of consumables, blood products and
unscheduled reviews, readmissions, or reoperations within
the first 28 days.
Safety outcomes included intraoperative and postoper-
ative complications that were classified according to the
Dindo and Clavien proposal [8]. Surgical efficacy outcomes
included surgical excision parameters. Perioperative care was
standardised for all patients as described at the departmental
enhanced recovery pathway. All patients were discharged
with an indwelling urinary catheter and readmitted on day 6
for catheter removal. In cases of urinary retention or postvoid
urine residuals >100mL, patients were recatheterised for
further 6-7 days. Failure to establish normal micturition after
the second week prompted urogynaecology referral. Patient
reported outcomes were measured 48 hrs following hospital
discharge and collected via standardised telephone interview.
Data were retrieved from electronic patient records and
case notes. The sample size was that of convenience. Full
propensity score matching was used in order to minimise
the mean difference of the distance between the treatment
(LRH) and the control group (ARH). Analysis was performed
with IBM SPSS statistics 20 (SPSS Inc., Chicago, Illinois)
software. Descriptive statistics were produced and normality
of distribution was assessed. Comparison of continuous
variables was performed with independent sample 𝑡-test for
the normally distributed data and the Mann–Whitney 𝑈 test
for the nonnormally distributed ones. In cases of categorical
variables Pearson’s chi square test was used. The statistical
significance of 𝑝 value was set at 5%.
3. Results
The ARH cases selected after propensity score full matching
presented a mean difference for distance of 0.0073 to the
36 cases of LRH. All 36 patients offered both options of
LRH and ARH opted for laparoscopic surgery. There were
no significant differences in the clinical and pathological
baseline characteristics between the LRH and the ARH
control cohort (Table 1).
There were no conversions to open surgery in the LRH
group. The intraoperative complication rate for ARH and
LRH was 23% and 16.6%, respectively (𝑝 = 0.5), while the
postoperative was 11.1% for both groups (Table 2).There were
3 urinary tract injuries in the LRH group and 1 in ARH group
(𝑝 = 0.3).These included a cystotomy that was identified and
treated laparoscopically.
The other 3 were ureteral injuries that presented on the
3rd postoperative week as urogenital fistulas and required
reoperation (2 in the LRH and 1 in the ARH cohort).
Two vascular injuries involved the internal iliac vein in
the ARH group and led to major haemorrhage and HDU
admissions. There was 1 obturator nerve injury in the LRH
group and 2 genitofemoral nerve injuries in the ARH group
resulting in thigh motor deficiency and severe chronic pain,
respectively. Blood loss was significantly less in the LRH
group both by estimation (mean of 189 versus 934mL) and by
measure of haemoglobin drop (2 versus 4.9 gr/dL). This led
to a significantly higher blood transfusion rate in the ARH
group (30.5% versus 2.7%, 𝑝 < 0.05). In each group vault
dehiscence occurred twice while in the ARH group there was
a further case of complete wound dehiscence. Wound, pelvic,
or urinary tract infections requiring intravenous antibiotics
were more common in the ARH cohort (8.3% versus 2.7%,
𝑝 = 0.3). One episode of deep venous thrombosis was
recorded in the LRH cohort. Overall there was no significant
difference in complications, according to Dindo and Clavien
classification (Table 3).
The number of 28-day unscheduled reviews, read-
missions, and reoperations was not significantly different
between the 2 cohorts (Table 2).
There was no significant difference in the closest excision
or involved margins, neither in the length of vaginal cuff
between groups. Lymph node harvest though was signifi-
cantly higher in the ARH group (Table 4).
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Table 1: Clinical and pathological baseline patient characteristics.
LRH (𝑛 = 36) ARH (𝑛 = 36) 𝑝 value
Age mean 44.6 41.2 0.2
Range (SD) 24–79 (12.2) 24–73 (12.7)
BMI mean 25.8 26.4 0.5
Range (SD) 19.6–35.8 (3.8) 19.5–34.7 (4.7)
ASA grade 𝑛 (%) 0.06
1 26 (72%) 18 (50%)
≥2 10 (28%) 18 (50%)
FIGO stage 𝑛 (%) 0.2
IA2 1 (2.7%) 0
IB1 33 (91.8%) 36 (100%)
IIA1∗ 2 (5.5%) 0
Histology 𝑛 (%) 0.3
Squamous cell 25 (69%) 20 (55%)
Adenocarcinoma 11 (31%) 16 (45%)
Grade 𝑛 (%) 0.3
1 5 (13.8%) 12 (33.3%)
2 16 (44.4%) 15 (41.6%)
3 3 (8.5%) 3 (8.5%)
n/a 12 (33.3) 6 (16.6%)
Tumor max dimension 0.6
Median 19.5mm 16mm
Range (IQ) 7–37 (30) 9–35 (12)
Nodal metastasis 𝑛 (%) 4 (11%) 2 (5.5%) 0.3
Previous minor abdominal surgery 𝑛 (%) 7 (19.4%) 13 (26%) 0.1
Follow-up duration (months) 36 36 1
∗These patients were preoperatively staged as IB1.
Table 2: Surgical safety outcomes.
LRH 𝑛 = 36 ARH 𝑛 = 36 𝑝 value
Intraoperative complication 6 (16.6%) 8 (22.2%) 0.5
Bladder 2 (5.5%) 0 0.1
Ureteric 1 (2.7%) 1 (2.7%) 1
Bowel 1 (2.7%) 0 0.3
Vascular 1 (2.7%) 2 (5.5%) 0.5
Nerve permanent 1 (2.7%) 2 (5.5%) 0.5
Haemorrhage > 1.5 lt 𝑛 (%) 0 3 (8.3%) 0.07
Postoperative complications 3 (11.1%) 4 (11.1%) 0.6
Surgical site complications
Wound/vault dehiscence 2 (5.5%) 3 (11.1%) 0.5
Infection 1 (2.7%) 3 (8.3%) 0.3
VTE 1 (2.7%) 0 0.3
Others
Admissions to HDU 0 2 (5.5%) 0.1
Blood transfusion 𝑛 (%) 1 (2.7%) 11 (30.5%) <0.05
28 days
A&E reviews 10 (27.7%) 8 (22.2%) 0.5
Readmissions 8 (22.2%) 5 (13.8%) 0.3
Reoperations (minor) 2 (5.5%) 5 (13.8%) 0.2
Reoperations (major) 3 (8.3%) 1 (2.7%) 0.3
VTE: venous thromboembolism, HDU: high dependency unit, and A&E: accidents and emergency.
4 Obstetrics and Gynecology International
Table 3: Overall complication grade.
Grade LRH (𝑛 = 36) ARH (𝑛 = 36) 𝑝 value
I 2 (5.5%) 2 (5.5%) 1
Id∗ 2 (5.5%) 2 (5.5%) 1
II 6 (16.6%) 8 (22.2%) 0.5
IIIb 5 (13.8%) 5 (13.8%) 1
IVa 0 1 (2.7%) 0.3
∗d: long-term disability.
Table 4: Surgical efficacy outcomes.
LRH 𝑛 = 36 ARH 𝑛 = 36 𝑝
Involved excision margins 𝑛 (%) 1 (2.8) 1 (2.8%) 1
Closest excision margin mean in mm 6.8 6.3 0.7
Range (SD) 0.5–14 (4.3) 0.5–20 (5)
Pelvic lymph node harvest mean (SD) 12.6 (5.3) 16.9 (8) <0.05
Vaginal vault length mean in mm (SD) 16.7 (9.4) 14.7 (9.8) 0.3
Operation time in minutes mean (SD) 206 (37.7) 159 (48.4) <0.05
Range 101–268 75–359
Days of hospital stay mean (SD) 2.31 (0.71) 4.17 (1.34) <0.05
Range 1–4 2–8
Bladder function recovery
TWOC > 1 𝑛 (%) 13 (36.2%) 4 (11.1%) <0.05
Urogynaecology review 𝑛 (%) 4 (11.1%) 4 (11.1%) 1
ISC 𝑛 (%) 1 (2.7%) 1 (2.7%) 1
Bowel function recovery
Constipation 𝑛 (%) 3 (8.3%) 1 (2.7%) 0.3
Adjuvant treatment 𝑛 (%) 5 (13.8%) 1 (2.7%) 0.08
Recurrence 0 0 1
TWOC: trial without catheter and ISC: intermittent self-catheterisation.
As expected the length of surgery was longer for LRH by
an average of 45 minutes but the length of stay was shorter by
an average of 1.86 days. There was no evidence of recurrent
disease in any cohort. Functional recovery of the bladder
was significantly delayed in the LRH cohort, with 36.2% of
patients requiring bladder catheterisation for more than 1
week compared to 11.1% of the ARH cohort (𝑝 < 0.05). The
degree of severe long-term bladder morbidity was the same
with only 1 patient requiring long-term intermittent self-
catheterisation in each cohort. Patient reported outcomes
showed some delay in bowel function recovery in the LRH
cohort while these of mobility, pain control, and oral intake
were favourable (Table 5).
The cost analysis showed that the expense of extra
operative time and equipment of LRH is almost compensated
by the reduced bed occupancy even within an enhanced
recovery programme (Table 6).
4. Discussion
Safety outcomes during the introduction phase of LRH are
comparable with these of standard practice with ARH. Given
the option, LRH was preferred patient choice despite the
higher urinary tract injury risk quoted during the process
of consent. The higher rate of urinary tract injuries during
LRH compared to ARH revealed by meta-analysis of large
retrospective cohorts [9] was also apparent in this study.
Unrecognised urinary tract injuries are a significant cause
of morbidity and a low threshold for ureteral stenting may
have clinical benefits.We also suggest the addition of a fourth
ancillary port so the surgeon can ergonomically complete the
dissection of each ureter by standing and operating from the
ipsilateral side. Surprisingly the only episode of deep venous
thrombosis (DVT) was recorded in the LRH cohort. Despite
the lower risk of DVT’s associated with laparoscopic surgery
[10], the increased lower extremity venous pressure during
prolonged Trendelenburg lithotomy positioning along with
the CO
2
pneumoperitoneum can increase this risk [11]. The
length of hospital stay for both LRH and ARH in this study
was lower than the one quoted in reported studies but the
reattendance rate was also high.
The significantly reduced lymph node harvest of LRH
has been reported in other studies [2]. Lymph node harvest
of both ARH and LRH in this study was lower compared
to some reports [2]. This is attributed to the limitation of
lymphadenectomies to level 1 [7] and the tailored radicality
in small volume tumours. Short-term recovery of bladder
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Table 5: Early postoperative PROM.
LRH ARH 𝑝
Mobility
Stairs 100% 91.3% 0.1
Out of house 62.5% 63% 0.9
Analgesia
Use of analgesia 63.9% 55.6% 0.7
Effective analgesia 72.2% 58.3% 0.4
GI
Eating & drinking 61.1% 52.8% 0.7
Nausea & vomiting 5.6% 11.1% 0.4
Bowels open 47.2% 63.9% <0.05
Use of laxatives 69.4% 38.9% <0.05
Wound problems 0 8.3% 0.1
PROM: patient reported outcome and GI: gastrointestinal.
Table 6: Direct hospital cost.
Cost of LRH ARH 𝑝
Standard surgical consumables 715.89 160.12
Extra perioperative expenses median (IQR) 412.2 (300) 307.5 (371) 0.9
Surgical time mean (SD) 3571.8 (651) 2759 (836) <0.05
Length of hospital stay median (IQR) 600 (300) 1200 (600) <0.05
Total median (IQR) 4746.9 (948) 4580.9 (1433) 0.08
and bowel function appeared delayed in the LRH cohort. An
increasing number of studies support the fact that laparo-
scopic [12] and more so robotic [13] surgery facilitate nerve
sparing surgical techniques, where branches of the inferior
hypogastric plexus are actively sought and preserved. It is
suggested that nerve sparing surgery offers better functional
postoperative recovery of the pelvic organs [14]. As with all
single centre retrospective studies generalisability of results is
one of the weaknesses. Prospective multicentre comparative
studies of standardised operative techniques using validated
patient reported outcome measures during the early and late
postoperative period can offer further insight.
The analysis of cohorts with the utilisation of propensity
score matching is aiming at reducing the effect of the
unavoidable selection bias in these nonrandomised studies.
Reported studies in the field have used similar confounders
in order to balance their groups [15]. Our operative times
and LoS were considerably lower compared to these studies
but so was the lymph node harvest. LRH seems to maintain
its favourable therapeutic profile over ARH in other reported
propensitymatched cohorts [16]. A large series of 130 propen-
sity score matched patients reported similar operative times
between the two groups, supporting therefore the fact that
after the introduction phase of LRH, the cost deriving from
the duration of surgery is equalising [17].
Cost analysis in this study refers to the introduction of
the laparoscopic technique. It is reasonable to expect that
if the indirect cost efficiencies of LRH are considered, the
overall cost for LRH is expected to be lower than this of
ARH. Introduction of LRH requires upfront investment in
equipment and staff training. Financial motives for quality
and innovation should be made available to hospitals in
order to enable investment in the safe introduction and
dissemination of LRH.
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